Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Statins reduce the incidence of cardiovascular events in persons with type 2 diabetes mellitus. However, the benefit of statins in such patients receiving hemodialysis, who are at high risk for cardiovascular disease and death, has not been examined. METHODS: We conducted a multicenter, randomized, double-blind, prospective study of 1255 subjects with type 2 diabetes mellitus receiving maintenance hemodialysis who were randomly assigned to receive 20 mg of atorvastatin per day or matching placebo. The primary end point was a composite of death from cardiac causes, nonfatal myocardial infarction, and stroke. Secondary end points included death from all causes and all cardiac and cerebrovascular events combined. RESULTS: After four weeks of treatment, the median level of low-density lipoprotein cholesterol was reduced by 42 percent among patients receiving atorvastatin, and among those receiving placebo it was reduced by 1.3 percent. During a median follow-up period of four years, 469 patients (37 percent) reached the primary end point, of whom 226 were assigned to atorvastatin and 243 to placebo (relative risk, 0.92; 95 percent confidence interval, 0.77 to 1.10; P=0.37). Atorvastatin had no significant effect on the individual components of the primary end point, except that the relative risk of fatal stroke among those receiving the drug was 2.03 (95 percent confidence interval, 1.05 to 3.93; P=0.04). Atorvastatin reduced the rate of all cardiac events combined (relative risk, 0.82; 95 percent confidence interval, 0.68 to 0.99; P=0.03, nominally significant) but not all cerebrovascular events combined (relative risk, 1.12; 95 percent confidence interval, 0.81 to 1.55; P=0.49) or total mortality (relative risk, 0.93; 95 percent confidence interval, 0.79 to 1.08; P=0.33). CONCLUSIONS: Atorvastatin had no statistically significant effect on the composite primary end point of cardiovascular death, nonfatal myocardial infarction, and stroke in patients with diabetes receiving hemodialysis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intensive glucose control (A1C levels <7% in T2D and <7.5% in T1D) in several clinical trials was found to reduce the risk of incident albuminuria (A2) and DKD onset.70,78,90,406–410”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [407]
In the citing paper
“Finally, in the UKPDS, wherein intensive treatment led to a mean end point A1C of 7.0%, hypoglycemia occurred in 1.8% of insulin-treated persons per year in the intensive group vs 0.7% of conventionally treated persons per year.407”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [407]
In the citing paper
“CKD is strongly associated with dyslipidemia, and CVD remains the leading cause of mortality among patients with CKD.25,26,28”
From Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL (2021) · cites this paper as [26]
In the citing paper
“CKD is strongly associated with dyslipidemia, and CVD remains the leading cause of mortality among patients with CKD.25,26,28”
From Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL (2021) · cites this paper as [26]
In the citing paper
“However, because of the gaps in data and negative study results, uncertainty exists over the benefits of applying proven CVD therapy in the general population to the CKD population, especially in patients with advanced kidney disease.”
From Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL (2021) · cites this paper as [26]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Clinical epidemiology of cardiovascular disease in chronic renal disease
Foley, R., Parfrey, P., & Sarnak, M. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820470 · Cited by 3,958
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Doqi, K. (2002) · American Journal of Kidney Diseases · Cited by 1,285
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
Himmelfarb, J., Stenvinkel, P., Ikizler, T. A., & Hakim, R. M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00600.x · Cited by 1,179
Research works printed but not linked: 2
- 1994, Lancet, 344, 1383
- Takayama F, 1998, Cell Mol Biol, 44, 1101
Cited by
Items 501–600 of 1,004
Cholesterol confusion and statin controversy
DuBroff, R. J., & de Lorgeril, M. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i7.404 · Cited by 68
The Cardio-Renal Interrelationship
Boudoulas, K. D., Triposkiadis, F. K., Parissis, J., Butler, J., & Boudoulas, H. K. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2016.12.003 · Cited by 60
Stavroulakis, K., Borowski, M., Torsello, G. B., Bisdas, T., Adili, F., Balzer, K. M., Billing, A., Böckler, D., Brixner, D., Debus, S. E., et al. (2017) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.05.115 · Cited by 61
Goldberg, R. B., Stone, N. J., & Grundy, S. M. (2020) · Diabetes Care · doi:10.2337/dci19-0036 · Cited by 58
Fellström, B., Holdaas, H., Jardine, A. G., Rose, H., Schmieder, R. E., Wilpshaar, W., & Zannad, F. M. (2007) · Kidney & Blood Pressure Research · doi:10.1159/000106803 · Cited by 60
Bertoluci, M. C., Moreira, R. O., Faludi, A. Á., Izar, M. C. D. O., Schaan, B. D., Valério, C. M., Bertolami, M. C., Chacra, A. P. M., Malachias, M. V. B., Vencio, S. A. C., et al. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0251-z · Cited by 69
Sollinger, D., Mohaupt, M. G., Wilhelm, A., Uehlinger, D. E., Frey, F. J., & Eisenberger, U. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.05.014 · Cited by 63
An Assessment of Statin Safety by Nephrologists
Kasiske, B. L., Wanner, C., & O'Neill, W. C. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.015 · Cited by 59
Self-citationNovel insights into vascular calcification
Ketteler, M., & Giachelli, C. M. (2006) · Kidney International · doi:10.1038/sj.ki.5001996 · Cited by 60
Winkelmayer, W. C., Charytan, D. M., Levin, R., & Avorn, J. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.009 · Cited by 59
Bakris, G. L., Vassalotti, J. A., Ritz, E., Wanner, C., Stergiou, G. S., Molitch, M. E., Nesto, R. W., Kaysen, G. A., & Sowers, J. R. (2010) · Kidney International · doi:10.1038/ki.2010.292 · Cited by 60
Self-citationA Randomized Trial of the Effect of Statin and Fibrate Therapy on Arterial Function in CKD
Dogra, G. K., Irish, A. B., Chan, D. C., & Watts, G. F. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.03.003 · Cited by 58
Statins in the management of dyslipidemia associated with chronic kidney disease
Epstein, M., & Vaziri, N. D. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.33 · Cited by 61
Simvastatin Prevents Coronary Microvascular Remodeling in Renovascular Hypertensive Pigs
Zhu, X.-Y., Daghini, E., Chade, A., Claudio Napoli, A., Ritman, E. L., Lerman, A., & Lerman, L. O. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006090976 · Cited by 58
HDL Cholesterol, Apolipoproteins, and Cardiovascular Risk in Hemodialysis Patients
Silbernagel, G., Genser, B., Drechsler, C., Scharnagl, H., Grammer, T. B., Stojaković, T., Krane, V., Ritz, E., Wanner, C., & März, W. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013080816 · Cited by 58
Self-citationBetjes, M. G. H., de Wit, E. A., Weimar, W. W., & Litjens, N. H. R. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq203 · Cited by 61
High Glycated Albumin and Mortality in Persons with Diabetes Mellitus on Hemodialysis
Chen, C. W., Drechsler, C., Suntharalingam, P., Karumanchi, S. A., Wanner, C., & Berg, A. H. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.258319 · Cited by 56
Self-citationMilionis, H. J., Ntaios, G., Korompoki, E., Vemmos, K. N., & Michel, P. (2019) · International Journal of Stroke · doi:10.1177/1747493019873594 · Cited by 61
Uremic Cardiomyopathy and Insulin Resistance: A Critical Role for Akt?
Semple, D. J., Smith, K., Bhandari, S., & Seymour, A. L. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009090900 · Cited by 58
VersorgungsLeitlinie, N. (2011) · Cited by 58
Reith, C. A., Blackwell, L. S., Emberson, J., Preiss, D., Spata, E., Davies, K., Halls, H. J., Harper, C., Holland, L., Wilson, K., et al. (2026) · The Lancet · doi:10.1016/s0140-6736(25)01578-8 · Cited by 68
Self-citationde Vries, F. M., Kolthof, J., Postma, M. J., Denig, P., & Hak, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111247 · Cited by 60
Bermúdez-López, M., Forné, C., Amigó, N., Božić, M., Arroyo, D., del Pino, T. B., Alonso, N., Cambray, S., y Pino, M. D. D. P., Mauricio, D., et al. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1620206 · Cited by 62
Boenink, R., Stel, V. S., Waldum-Grevbo, B. E., Collart, F., Kerschbaum, J., Heaf, J. G., Meester, J. D., Finne, P., García-Marcos, S. A., Evans, M., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.05.039 · Cited by 59
In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients
Panichi, V., Paoletti, S., Mantuano, E., Manca-Rizza, G., Filippi, C., Santi, S., Taccola, D., Donadio, C., Tramonti, G., Innocenti, M., et al. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi224 · Cited by 64
Moon, J., & Bogle, R. (2006) · BMJ · doi:10.1136/bmj.332.7554.1344 · Cited by 57
Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein
Kon, V., Yang, H., & Fazio, S. (2015) · Archives of Medical Research · doi:10.1016/j.arcmed.2015.05.009 · Cited by 56
Coll, B., Betriu, À., Martínez‐Alonso, M., Borràs, M., Craver, L., Amoedo, M. L., Marco, M. {. }., Sarró, F., Junyent, M., Valdivielso, J. M., et al. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq109 · Cited by 56
Ravel, V., Molnar, M. Z., Streja, E., Kim, J. C., Victoroff, A., Jing, J., Benner, D., Norris, K. C., Kovesdy, C. P., Kopple, J. D., et al. (2013) · Journal of Nutrition · doi:10.3945/jn.112.169722 · Cited by 56
The Success Story of LDL Cholesterol Lowering
Pedersen, T. R. (2016) · Circulation Research · doi:10.1161/circresaha.115.306297 · Cited by 56
Tsai, M., & Tarng, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010117 · Cited by 60
Renal function, atherothrombosis extent, and outcomes in high-risk patients
Dumaine, R. L., Montalescot, G., Steg, P. G., Ohman, E. M., Eagle, K. A., & Bhatt, D. L. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.05.011 · Cited by 56
Hyre, A. D., Fox, C. S., Astor, B. C., Cohen, A. J., & Muntner, P. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.09.017 · Cited by 55
Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
Drapkina, O. M., Васильевна, К. А., Калинина, А. М., Avdeev, S. N., Викторович, А. М., Алексеева, Л. И., Almazova, I. I., Andreenko, Е. Y., Antipushina, D. N., Balanova, Y. А., et al. (2024) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2024-3996 · Cited by 65
Gurm, H. S., Gore, J. M., Anderson, F. A., Wyman, A. S., Fox, K. A. A., Steg, P. G., & Eagle, K. A. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.07.062 · Cited by 55
Chronic Kidney Disease as a Coronary Disease Equivalent—A Comparison with Diabetes over a Decade
Debella, Y. T., Giduma, H. D., Light, R. P., & Agarwal, R. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10271110 · Cited by 55
Circulating metabolic biomarkers of renal function in diabetic and non-diabetic populations
Barrios, C., Zierer, J., Würtz, P., Haller, T., Metspalu, A., Gieger, C., Thorand, B., Meisinger, C., Waldenberger, M., Raitakari, O. T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33507-7 · Cited by 57
O’Fee, K., Deych, E., Ciani, O., & Brown, D. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.5726 · Cited by 58
Pre-transplant predictors of cerebrovascular events after kidney transplantation
Aull‐Watschinger, S., Konstantin, H., Demetriou, D., Schillinger, M., Habicht, A., Hörl, W. H., & Watschinger, B. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm766 · Cited by 55
Lipid Abnormalities and Cardiovascular Risk in Renal Disease
Ritz, E., & Wanner, C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101128 · Cited by 59
Self-citationStatins in the Treatment of Chronic Heart Failure: A Systematic Review
van der Harst, P., Voors, A. A., van Gilst, W. H., Böhm, M., & van Veldhuisen, D. J. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030333 · Cited by 55
Friedman, A. N., Yu, Z., Tabbey, R., Denski, C., Tamez, H., Wenger, J., Thadhani, R., Li, Y., & Watkins, B. A. (2013) · Kidney International · doi:10.1038/ki.2013.4 · Cited by 54
Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link?
Jager, K. J., Lindholm, B., Goldsmith, D. J. A., Fliser, D., Więcek, A., Süleymanlar, G., Ortíz, A., Massy, Z. A., Martínez‐Castelao, A., Agarwal, R., et al. (2011) · Kidney International Supplements · doi:10.1038/kisup.2011.7 · Cited by 65
Cardiorenal syndrome type 4: From chronic kidney disease to cardiovascular impairment
Granata, A. R. M., Clementi, A., Virzì, G. M., Brocca, A., de Cal, M., Scarfia, R. V., Zanoli, L., Ronco, C., Corrao, S., & Malatino, L. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.02.019 · Cited by 59
Arterial Stiffness and Chronic Kidney Disease
Garnier, A., & Briet, M. B. (2015) · Pulse · doi:10.1159/000443616 · Cited by 65
Charytan, D. M., Desai, M., Mathur, M. B., Stern, N. M., Brooks, M. M., Krzych, Ł. J., Schuler, G. C., Kaehler, J., Rodriguez-Granillo, A. M., Hueb, W. A., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.03.033 · Cited by 54
Meta-analysis of statins in chronic kidney disease: who benefits?
Messow, C., & Isles, C. (2017) · QJM · doi:10.1093/qjmed/hcx040 · Cited by 58
AGEs/RAGE in CKD: irreversible metabolic memory road toward CVD?
Koyama, H., & Nishizawà, Y. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02298.x · Cited by 57
Statin Use Is Associated with Prolonged Survival of Renal Transplant Recipients
Wiesbauer, F., Heinze, G., Mitterbauer, C., Harnoncourt, F., Diaeresisrl, W. H. H., & Oberbauer, R. W. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008010101 · Cited by 58
Vitamin D levels and early mortality among incident hemodialysis patients
Mailliez, S., Shahapuni, I., Lecaque, C., Massy, Z. A., Choukroun, G. J., & Fournier, A. E. (2008) · Kidney International · doi:10.1038/ki.2008.168 · Cited by 55
Legacy effects of statins on cardiovascular and all-cause mortality: a meta-analysis
Nayak, A., Hayen, A. D., Zhu, L., McGeechan, K., Glasziou, P., Irwig, L., Doust, J. A., Gregory, G. A., & Bell, K. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020584 · Cited by 54
The role of statins in clinical medicine -LDL - cholesterol lowering and beyond
Rutishauser, J. (2006) · Swiss Medical Weekly · doi:10.4414/smw.2006.11170 · Cited by 53
de Lorgeril, M., Salen, P., Defaye, P., & Rabaeus, M. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-5 · Cited by 55
de Bie, M. K., Lekkerkerker, J. C., van Dam, B., Gaasbeek, A., van Buren, M., Putter, H., van Erven, L., Bax, J. J., Schalij, M. J., Rabelink, T. J., et al. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802237343 · Cited by 55
Atorvastatin: safety and tolerability
Athyros, V. G., Τζιόμαλος, Κ., Karagiannis, A. I., & Mikhailidis, D. P. (2010) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2010.495385 · Cited by 54
Evolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease
Bansal, N. (2017) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2016.12.002 · Cited by 54
Blood pressure targets for hemodialysis patients
Turner, J. M., & Peixoto, A. J. (2017) · Kidney International · doi:10.1016/j.kint.2017.01.038 · Cited by 55
Remppis, A., & Ritz, E. (2008) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2008.00457.x · Cited by 57
Self-citationJimbo, R., & Shimosawa, T. (2014) · International Journal of Hypertension · doi:10.1155/2014/381082 · Cited by 52
Combination therapy in dyslipidemia: Where are we now?
Catapano, A. L., Farnier, M., Foody, J. M., Toth, P. P., Tomassini, J. E., Brudi, P., & Tershakovec, A. M. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.09.026 · Cited by 55
Evidence-Based Cardiology in Hemodialysis Patients
Allon, M. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013060632 · Cited by 59
Pfau, A., Ermer, T., Coca, S. G., Tio, M. C., Genser, B., Reichel, M., Finkelstein, F. O., März, W., Wanner, C., Waikar, S. S., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020121793 · Cited by 48
Self-citationReducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives
Sander, D., & Kearney, M. T. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5143-1 · Cited by 54
Trion, A., Schutte, C. I., Bax, W. H., Jukema, J. W., & van der Laarse, A. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9608-1 · Cited by 52
The kidney disease wasting: Inflammation, oxidative stress, and diet‐gene interaction
Kalantar‐Zadeh, K., & Balakrishnan, V. S. (2006) · Hemodialysis International · doi:10.1111/j.1542-4758.2006.00124.x · Cited by 56
Lipid Changes and Statins in Chronic Renal Insufficiency
Ritz, E., & Wanner, C. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080919 · Cited by 52
Self-citationDeAngelis, R. A., Reis, E. S., Ricklin, D., & Lambris, J. D. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.012 · Cited by 52
Managing the Burden of Chronic Kidney Disease
Thorp, M. L., Eastman, L., Smith, D. H., & Johnson, E. S. (2006) · Disease Management · doi:10.1089/dis.2006.9.115 · Cited by 51
Bonomini, M., Liberato, L. D., Rosso, G. D., Stingone, A., Marinangeli, G., Consoli, A., Bertoli, S. V., Vecchi, A. D., Bosi, E., Russo, R., et al. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.04.007 · Cited by 51
Fassett, R. G., Coombes, J. S., Packham, D., Fairley, K. F., & Kincaid‐Smith, P. (2009) · Scandinavian Journal of Urology and Nephrology · doi:10.3109/00365590903359908 · Cited by 52
Liebman, S. E., Lamontagne, S., Huang, L., Messing, S. P., & Bushinsky, D. A. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.03.025 · Cited by 54
Cholesterol Synthesis, Cholesterol Absorption, and Mortality in Hemodialysis Patients
Rogacev, K. S., Pinsdorf, T., Weingärtner, O., Gerhart, M. K., Welzel, E., van Bentum, K., Popp, J., Menzner, A., Fliser, D., Lütjohann, D., et al. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05170511 · Cited by 51
Evidence for the Prevention and Treatment of Stroke in Dialysis Patients
Herrington, W. G., Haynes, R., Staplin, N., Emberson, J., Baigent, C., & Landray, M. (2014) · Seminars in Dialysis · doi:10.1111/sdi.12281 · Cited by 55
Graham-Brown, M. P. M., Patel, A. S., Stensel, D. J., March, D. S., Marsh, A.-M., McAdam, J., McCann, G. P., & Burton, J. O. (2017) · BioMed Research International · doi:10.1155/2017/5453606 · Cited by 58
Serum indoxyl sulfate predicts adverse cardiovascular events in patients with chronic kidney disease
Fan, P., Chang, C., Lin, C., Lee, C., Chen, Y., Chu, P., Kou, G., Lu, Y.-A., Yang, C., & Chen, Y. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2019.03.005 · Cited by 51
Altered vitamin K biodistribution and metabolism in experimental and human chronic kidney disease
Kaesler, N., Schreibing, F., Speer, T., de la Puente-Secades, S., Rapp, N., Drechsler, C., Kabgani, N., Kuppe, C., Boor, P., Jankowski, V., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.10.029 · Cited by 51
Rakhit, D. J., Marwick, T. H., Armstrong, K. A., Johnson, D. W., Leano, R., & Isbel, N. M. (2006) · Heart · doi:10.1136/hrt.2005.074393 · Cited by 51
Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis
Ortíz, A., Massy, Z. A., Fliser, D., Lindholm, B., Więcek, A., Martínez‐Castelao, A., Covic, A. C., Goldsmith, D. J. A., Süleymanlar, G., London, G. M., et al. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.170 · Cited by 50
Chen, Y., Ruan, X. Z., Li, Q., Huang, A., Moorhead, J. F., Powis, S. H., & Varghese, Z. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00209.2007 · Cited by 50
Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease
Charytan, D. M. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000067 · Cited by 50
Malnutrition-Inflammation Modifies the Relationship of Cholesterol with Cardiovascular Disease
Contreras, G. N., Hu, B., Astor, B. C., Greene, T., Erlinger, T. P., Kusek, J. W., Lipkowitz, M. S., Lewis, J., Randall, O. S., Hebert, L. A., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121285 · Cited by 50
Rahimi, K., Majoni, W., Merhi, A., & Emberson, J. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs005 · Cited by 50
Lee, M. J., Park, J. T., Han, S. H., Kim, Y.-L., Kim, Y. S., Yang, C. W., Kim, N.-H., Kang, S., Kim, H. J., & Yoo, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177499 · Cited by 50
Riaz, H., Khan, A. R., Khan, M. S., Rehman, K. A., Alansari, S. A. R., Gheyath, B., Raza, S., Barakat, A., Luni, F. K., Ahmed, H., et al. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.05.046 · Cited by 50
Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients
Lovre, D., Shah, S., Sihota, A., & Fonseca, V. A. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.006 · Cited by 46
Verdoodt, A., Honoré, P. M., Jacobs, R., Waele, E. D., Gorp, V. V., Regt, J. D., & Spapen, H. D. (2018) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2018-0005 · Cited by 55
Vonbank, A., Drexel, H., Agewall, S., Lewis, B. S., Dopheide, J. F., Kjeldsen, K. P., Ceconi, C., Savarese, G., Rosano, G. M. C., Waßmann, S., et al. (2018) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvy028 · Cited by 51
Rambod, M., Kovesdy, C. P., & Kalantar‐Zadeh, K. (2008) · Nature Reviews Nephrology · doi:10.1038/ncpneph0834 · Cited by 50
Komaba, H., Moriwaki, K., Goto, S., Yamada, S., Taniguchi, M., Kakuta, T., Kamae, I., & Fukagawa, M. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.12.034 · Cited by 50
Reverse epidemiology: paradoxical observations in haemodialysis patients.
Nurmohamed, A. S., & Nubé, M. J. (2005) · PubMed · Cited by 50
New perspectives on CKD-induced dyslipidemia
Bermúdez-López, M., Arroyo, D., Betriu, À., Masana, L., Fernández, E., & Valdivielso, J. M. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1369961 · Cited by 54
Cholesterol-Lowering Agents: Statins—For Everyone?
Hadjiphilippou, S., & Ray, K. K. (2019) · Circulation Research · doi:10.1161/circresaha.118.313245 · Cited by 49
Bétrisey, S., Haller, M. L., Efthimiou, O., Speierer, A., Giovane, C. D., Moutzouri, E., Blum, M. R., Aujesky, D., Rodondi, N., & Gencer, B. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.030714 · Cited by 49
Statins for the Prevention of Stroke: A Meta-Analysis of Randomized Controlled Trials
Wang, W., & Zhang, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092388 · Cited by 52
Current and emerging treatment options for the elderly patient with chronic kidney disease
Fassett, R. G. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s39763 · Cited by 60
Krane, V., Winkler, K., Drechsler, C., Lilienthal, J., März, W., & Wanner, C. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.06.029 · Cited by 52
Self-citationRinat, C., Becker‐Cohen, R., Nir, A., Feinstein, S., Shemesh, D., Algur, N., Shalom, E. B., Farber, B. A., & Frishberg, Y. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp570 · Cited by 54
Lipid control in patients with diabetes mellitus
Betteridge, D. J. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.23 · Cited by 58
Chertow, G. M., Correa-Rotter, R., Block, G. A., Drüeke, T. B., Floege, J., Goodman, W. G., Herzog, C. A., Kubo, Y., London, G. M., Mahaffey, K. W., et al. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr777 · Cited by 49
Regazzoni, L., Vecchio, L. D., Altomare, A., Yeum, K., Cusi, D., Locatelli, F., Carini, M., & Aldini, G. (2012) · Free Radical Research · doi:10.3109/10715762.2012.756139 · Cited by 55
Metadata
- Authors
- Wanner, C., Krane, V., März, W., Olschewski, M., Mann, J. F. E., Ruf, G., & Ritz, E.
- Affiliations
- University of Würzburg (DE)
- Medical University of Graz (AT)
- University Medical Center Freiburg (DE)
- München Klinik Schwabing (DE)
- Pfizer (Germany) (DE)
- Heidelberg University (DE)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-07-21
- Volume
- 353
- Issue
- 3
- Pages
- 238-248
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2110601215
- Cited by
- 2,614
- References
- 30
- Citations by year
- 2026: 74 · 2025: 51 · 2024: 66 · 2023: 76 · 2022: 90 · 2021: 92 · 2020: 97 · 2019: 110 · 2018: 96 · 2017: 104 · 2016: 110 · 2015: 132 · 2014: 153 · 2013: 162 · 2012: 185
- FWCI
- 135.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- atorvastatin, type 2 diabetes, hemodialysis, statins, cardiovascular events, myocardial infarction, stroke, cardiovascular mortality, LDL cholesterol, end-stage renal disease
- MeSH terms
- Atorvastatin, Aged, Cerebrovascular Disorders, Diabetes Mellitus, Type 2, Double-Blind Method, Female, Heart Diseases, Renal Dialysis, Heptanoic Acids, Humans, Cholesterol, LDL, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Pyrroles, Incidence, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.